| Literature DB >> 28918936 |
Guolin Li1, Cen Xie2, Siyu Lu3, Robert G Nichols4, Yuan Tian4, Licen Li3, Daxeshkumar Patel2, Yinyan Ma5, Chad N Brocker2, Tingting Yan2, Kristopher W Krausz2, Rong Xiang6, Oksana Gavrilova5, Andrew D Patterson4, Frank J Gonzalez7.
Abstract
While activation of beige thermogenesis is a promising approach for treatment of obesity-associated diseases, there are currently no known pharmacological means of inducing beiging in humans. Intermittent fasting is an effective and natural strategy for weight control, but the mechanism for its efficacy is poorly understood. Here, we show that an every-other-day fasting (EODF) regimen selectively stimulates beige fat development within white adipose tissue and dramatically ameliorates obesity, insulin resistance, and hepatic steatosis. EODF treatment results in a shift in the gut microbiota composition leading to elevation of the fermentation products acetate and lactate and to the selective upregulation of monocarboxylate transporter 1 expression in beige cells. Microbiota-depleted mice are resistance to EODF-induced beiging, while transplantation of the microbiota from EODF-treated mice to microbiota-depleted mice activates beiging and improves metabolic homeostasis. These findings provide a new gut-microbiota-driven mechanism for activating adipose tissue browning and treating metabolic diseases. Published by Elsevier Inc.Entities:
Keywords: beige adipocytes; browning; every-other-day fasting (EODF); gut microbiota; intermittent fasting; metabolic syndrome; obesity; short-chain fatty acid
Mesh:
Substances:
Year: 2017 PMID: 28918936 PMCID: PMC5668683 DOI: 10.1016/j.cmet.2017.08.019
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287